ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,083.57
      0.36%
      US Tech 100
      21,184.00
      0.00%
      Dow Jones
      44,747.63
      -0.28%
      Brent Oil
      74.865
      0.94%
      Bitcoin
      96,912.57
      0.35%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Altamira Therapeutics Ltd (CYTO) Quote

      Altamira Therapeutics Ltd

      Altamira Therapeutics Ltd (CYTO)

      Cytophage Technologies Ltd
      0.30
      0.00
      (0.00%)
      Closed February 07 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.30
      Bid
      0.2921
      Ask
      0.2922
      Volume
      -
      0.00 Day's Range 0.00
      0.30 52 Week Range 3.49
      Market Cap
      969k
      Previous Close
      0.30
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      87,491
      Shares Outstanding
      3,230,000
      Dividend Yield
      -
      PE Ratio
      -2.54
      Earnings Per Share (EPS)
      -1.2
      Revenue
      158k
      Net Profit
      -3.87M

      About Altamira Therapeutics Ltd

      Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore TM / SemaPhore TM delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-4... Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore TM / SemaPhore TM delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. In addition, Altamira holds a 49% stake (with additional economic rights) in Altamira Medica AG, its commercial-stage legacy asset Bentrio®, an OTC nasal spray for allergic rhinitis. Further, the Company is in the process of partnering / divesting its inner ear legacy assets. Show more

      Sector
      Med, Dental, Hosp Eq-whsl
      Industry
      Med, Dental, Hosp Eq-whsl
      Website
      altamiratherapeutics.com
      Headquarters
      Basel, Che
      Founded
      -
      Altamira Therapeutics Ltd is listed in the Med, Dental, Hosp Eq-whsl sector of the NASDAQ with ticker CYTO. The last closing price for Altamira Therapeutics was $0.30. Over the last year, Altamira Therapeutics shares have traded in a share price range of $ 0.30 to $ 3.49.

      Altamira Therapeutics currently has 3,230,000 shares outstanding. The market capitalization of Altamira Therapeutics is $969,000 . Altamira Therapeutics has a price to earnings ratio (PE ratio) of -2.54.

      Ask ADVFN Intelligence (AI)

      CYTO Latest News

      More News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 20 2024
      Edgar (US Regulatory)

      Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets

      HAMILTON, BERMUDA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Trading to continue under ticker symbol “CYTOF”No reverse stock split planned Altamira Therapeutics Ltd. (“Altamira” or the “Company”...

      December 20 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      October 04 2024
      Edgar (US Regulatory)

      Altamira Therapeutics Provides Update on Nasdaq Listing

      Hamilton, Bermuda, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO) today announced that it received on September 30, 2024, a letter from...

      October 04 2024
      GlobeNewswire Inc.

      Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray

      Hamilton, Bermuda, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Certification to ISO 13485 extended to also include production process  Supports Bentrio growth strategy together with strategic contract...

      September 27 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      September 24 2024
      Edgar (US Regulatory)

      Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results

      Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within core activities in RNA delivery, supported by move into new...

      September 24 2024
      GlobeNewswire Inc.

      Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024

      Hamilton, Bermuda, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...

      September 20 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      September 19 2024
      Edgar (US Regulatory)

      Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering

      Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked...

      September 19 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.30.30.300CS
      4000.30.30.300CS
      12-0.14-31.81818181820.440.5750.3874910.43804012CS
      26-0.61-67.0329670330.911.33440.32366840.85664949CS
      52-1.59-84.1269841271.893.490.36645251.7868865CS
      156-483.7-99.93801652894848600.3221723156.54152225CS
      260-239.7-99.87524015480.31796170181.72866324CS

      CYTO - Frequently Asked Questions (FAQ)

      What is the current Altamira Therapeutics share price?
      The current share price of Altamira Therapeutics is $ 0.30
      How many Altamira Therapeutics shares are in issue?
      Altamira Therapeutics has 3,230,000 shares in issue
      What is the market cap of Altamira Therapeutics?
      The market capitalisation of Altamira Therapeutics is USD 969k
      What is the 1 year trading range for Altamira Therapeutics share price?
      Altamira Therapeutics has traded in the range of $ 0.30 to $ 3.49 during the past year
      What is the PE ratio of Altamira Therapeutics?
      The price to earnings ratio of Altamira Therapeutics is -2.54
      What is the cash to sales ratio of Altamira Therapeutics?
      The cash to sales ratio of Altamira Therapeutics is 62.17
      What is the reporting currency for Altamira Therapeutics?
      Altamira Therapeutics reports financial results in CHF
      What is the latest annual turnover for Altamira Therapeutics?
      The latest annual turnover of Altamira Therapeutics is CHF 158k
      What is the latest annual profit for Altamira Therapeutics?
      The latest annual profit of Altamira Therapeutics is CHF -3.87M
      What is the registered address of Altamira Therapeutics?
      The registered address for Altamira Therapeutics is DORNACHERSTRASSE 210, BASEL, 4053
      What is the Altamira Therapeutics website address?
      The website address for Altamira Therapeutics is altamiratherapeutics.com
      Which industry sector does Altamira Therapeutics operate in?
      Altamira Therapeutics operates in the MED, DENTAL, HOSP EQ-WHSL sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 17.06
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 75.9605
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.83
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.82
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 17.06
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 75.9605
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.83
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.82
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 17.06
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 75.9605
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.83
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.82
      (0.00%)
      		0

      CYTO Discussion

      View Posts
      Werbe Werbe 2 weeks ago
      Healthy bids growing @ .10. Gonna see them start pushing up again.
      👍️0
      Werbe Werbe 2 weeks ago
      Thats a wicked spread, whats up with that?
      👍️0
      Werbe Werbe 2 weeks ago
      Lets sprout some wings baby.
      👍️0
      Werbe Werbe 1 month ago
      Way undervalued here, lot of moving up room to go.
      👍️0
      Werbe Werbe 1 month ago
      Major overreaction here, especially with company saying no RS now. L2 shows thin running ahead, heavy volume going to make this a moonshot.
      👍️0
      Werbe Werbe 1 month ago
      .80 les go go go!
      👍️0
      Werbe Werbe 1 month ago
      $377k market cap lol, dont matter what this is an atrocity.
      👍️0
      Werbe Werbe 2 months ago
      Trying 2 grab some cheapies.
      👍️0
      Renee Renee 2 months ago
      CYTO changed to CYTOF. Delisted from the Nasdaq to the OTC. PPS dropped 31% from .41 to .28.

      https://otce.finra.org/otce/dailyList?viewType=Additions
      👍️0
      glenn1919 glenn1919 3 months ago
      CYTO..............................https://stockcharts.com/h-sc/ui?s=CYTO&p=W&b=5&g=0&id=p86431144783
      👍️0
      tw0122 tw0122 3 months ago
      Bottom in .40-.46 how is that nasal spray doing. Grabbed .44s yesterday 
      👍️0
      Monksdream Monksdream 5 months ago
      CYTO new 52 week low
      https://investorshub.advfn.com/uimage/uploads/2024/9/12/crbhcIMG_1697.gif
      👍️0
      glenn1919 glenn1919 6 months ago
      CYTO.......................................https://stockcharts.com/h-sc/ui?s=CYTO&p=W&b=5&g=0&id=p86431144783
      👍️0
      tw0122 tw0122 6 months ago
      Animal testing reaping fruits
      👍️0
      Monksdream Monksdream 7 months ago
      CYTO new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      CYTO new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      CYTO new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      CYTO 10Q expected 5/28
      👍️0
      glenn1919 glenn1919 8 months ago
      CYTO........................https://stockcharts.com/h-sc/ui?s=CYTO&p=W&b=5&g=0&id=p86431144783
      👍️0
      Awl416 Awl416 9 months ago
      Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
      👍️0
      Monksdream Monksdream 10 months ago
      CYTO new 52 lo
      👍️0
      Monksdream Monksdream 10 months ago
      CYTO under $2
      👍️0
      Monksdream Monksdream 10 months ago
      CYTO under $3
      👍️0
      TheFinalCD TheFinalCD 10 months ago
      $cyto 2.72 news https://healthstockshub.com/news/nasdaq/cyto/altamira-therapeutics-announces-collaboration-with-univercells-group-on-nanoparticle-delivered-mrna-vaccines

      in @ 2.52
      👍️0
      Awl416 Awl416 10 months ago
      PM pop
      👍️0
      Chuxster Chuxster 11 months ago
      Bought at 1.71 and 1.72 respectively, yesterday.
      👍️0
      Monksdream Monksdream 1 year ago
      And then a pr this morning
      👍️0
      Monksdream Monksdream 1 year ago
      CYTO new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      CYTO new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      CYTO new 52 week low
      👍️0
      OffTheGrid OffTheGrid 1 year ago
      Watching for entry
      👍️0
      CELTICAPPLE CELTICAPPLE 1 year ago
      The dreaded reverse split.
      👍️0
      Invest-in-America Invest-in-America 1 year ago
      CYTO: Whelp, 95%+ down right now in today's Pre-M, so, maybe it's time to "GRAB THOSE CHEAPIES"???
      👍️0
      1hot toddy 1hot toddy 1 year ago
      sorry boys another rs tomorrow 20/1 then they will issue more shares as co has 34k. you guys should of sold instead of bought.

      good luck ur going to need it. get ready for the ride down. hope im wrong 4 your sake
      👍️0
      hondaboost hondaboost 1 year ago
      CYTO will do financing?
      👍️0
      luckydude777 luckydude777 1 year ago
      Loving it!
      👍️0
      stockforce stockforce 1 year ago
      They announced this webcast on Tuesday last week and didn’t release any other news after that. It surely sounds like some major updates will be announced today.
      👍️0
      Sunset Kid Sunset Kid 1 year ago
      Best case scenerio, they release some good news before the webcast. That would be the logical way to play this if they truly have something big for investors. 12 tense hours to go, lol. Happy to be in regardless. Hope it goes over .60 in premarket. Good luck everyone (except shorty). God Bless us too!
      👍️0
      nathanial nathanial 1 year ago
      Why hold a web call an hour before opening on Monday unless you have something really good to say? That's just crazy to put out and average web call on a Monday before the open with a nothing burger. They are doing this on purpose and want the whole trading day before them to react..
      👍️ 1
      buccaneer1961 buccaneer1961 1 year ago
      I said...
      👍️0
      TheFinalCD TheFinalCD 1 year ago
      .50 dip would help if the company had an X acct and tweeted something like the OTC stock pumps

      in between their upcoming Investor call (which usually is a sell on CC day)

      Altamira Therapeutics to Host Investor & Business Update Call on December 11th
      December 05 2023 - 12:54PM



      HAMILTON, BERMUDA--December 5, 2023--Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an Investor and Business Update Call on Monday, December 11, 2023, 8:30 a.m. ET. The presentation will be available via teleconference or webcast with audio and presenter-controlled slides.
      Webcast Access:

      Date: Monday, December 11, 2023
      Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)
      Webcast URL: https://edge.media-server.com/mmc/p/k7s8zdkg
      👍️ 1
      buccaneer1961 buccaneer1961 1 year ago
      Nice to see squeeze to 2.00
      👍️ 1
      buccaneer1961 buccaneer1961 1 year ago
      Dadgum that's high...shorts in trouble
      👍️ 1
      Sunset Kid Sunset Kid 1 year ago
      'Cost To Borrow' The CTB represents the fee that short sellers must pay to borrow stock. According to The Street, the typical CTB fee hovers between 0.3% and 3%. A stock's CTB rises when short seller demand is high and falls when regular investor demand is high
      👍️0
      buccaneer1961 buccaneer1961 1 year ago
      Ctb?? What is that?
      👍️0
      Penny_God Penny_God 1 year ago
      337% CTB on this. Shorts are in hell.
      👍️ 1
      S-BEES-BUMBLEBEE S-BEES-BUMBLEBEE 1 year ago
      $CYTO >>> KAAAABBBBOOOOOOOOOOOOOOOMMMMMMMMMM!!! $$$$$$$$$



      $$$CYTO$$$
      👍️0
      da_stock_analyst da_stock_analyst 1 year ago
      #CYTO 🔥 $1 tomorrow? Looking very bullish $CYTO
      👍️0
      buccaneer1961 buccaneer1961 1 year ago
      Get lost organ....your a lying bag of pig internals
      👍️0
      halbroke1 halbroke1 1 year ago
      CYTO $$$ HOPE TO SEE HKD TYPE MOVE HERE..
      👍️0

      Your Recent History

      NASDAQ
      CYTO
      Altamira Therapeutics
      TSXV
      RTCC.P
      Risetech Capital
      BIT
      F28832
      Vontobel Financial Produ...
      TSXV
      CYTO
      Cytophage Technologies
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads